The people of India are hopeful since a company named Bharat Biotech International Limited (BBIL) from Hyderabad is association with the Indian Council of Medical Research (ICMR) got approval from the Drug Controller General of India (DCGI) to conduct Phase I, II Human clinical trials for the COVID-19 vaccine called “Covaxin”.
As per the reports, Bharat Biotech and the ICMR are planning to launch Covaxin by this Indepe....
Tags : Covaxin, Bharat Biotech, ICMR, NIV, COVID-19 vaccine, DCGI,
comments (0)